Τόμος 18 (2004) – Τεύχος 1 – Άρθρο 15 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 18 (2004) – Issue 1 – Article 15 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Structural and functional characterization of the dimerization sites of Soluble Guanylyl Cyclase
Author Z. Zhou1, Ch. Roussos1 and A. Papapetropoulos1,2

1George P. Livanos-Marianthi Simou Laboratories, Department of Critical Care and Pulmonary Services, Evangelismos Hospital, University of Athens School of Medicine and 2Department of Molecular Pharmacology, School of Pharmacy, University of Patras, Patra, Greece

Citation Zhou, Z., Roussos, C. and Papapetropoulos, A.: Structural and functional characterization of the dimerization sites of Soluble Guanylyl Cyclase, Epitheorese Klin. Farmakol. Farmakokinet. 18(1): 36-38 (2004)
Publication Date Accepted for publication: 2004
Full Text Language English
Order – Buy Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) pharmakonpress[at]pharmakonpress[.]gr
Keywords sGC, Soluble Quanylyl Cyclase
Other Terms review article
Summary Soluble guanylyl cyclase (sGC) is a ubiquitous enzyme that functions as a receptor for nitric oxide. In spite of the obligate heterodimeric nature of sGC, the sequence mediating subunit association have remained elusive. Our initial screening for the interaction site(s) demonstrated that two regions of each subunit, i.e. the regulatory domain and the central region, are involved in heterodimer formation of the most common sGC isoenzyme, α1/ β1. To precisely map the relevant segments in the βι subunit, we constructed multiple N- and C-terminal deletion variants and co-transfected them with full-length α1 in COS cells. Immunoprécipitation revealed that a sequence segment spanning positions 204 to 408 mediates binding of α1 to β1. Fusion of the α1 dimerization region to EGFP conferred binding activity to the recipient protein. Analysis of deletion constructs lacking portions of the dimerization region identified two distinct sites in βι that contribute importantly to its interaction with α1 i.e. an N- terminal binding site (NBS) covering positions 204 to 244 and a C-terminal binding site at 379 to 408 (CBS). Both NBS and CBS are crucial for sGC function as deletion of either site rendered sGC inactive. We conclude that the dimerization region of β1 extends over 205 residues of its regulatory and central domains, and that two discontinuous sites of 41 and 30 residues, respectively facilitate binding of β1 to the α1 subunit of sGC.
References 1.         Lucas K.A., Pitari G.M., Kazerounian S., RuizOStewart I., Park J., Schulz S., Chepenik K.P., Waldman S.A.: Pharmacol. Rev. 52. 375-414 (2000)

2.        Moncada S., Palmer R.M., Higgs E.A.: Pharmacol. Rev. 43: 109-142 (1991)

3.        Potter L.R., Hunter T.: J. Biol. Chem. 276: 6057-6060 (20010

4.        Hobbs A.J.: Trends Pharmacol. 18: 484-491 (1997)

5.        Andreopoulos S., Papapetropoulos A.: Gen. Pharmacol. 34: 147-157 (2000)

6.        Koesling D., Friebe A.: Rev. Physiol. Biochem. Pharmacol. 135: 41-65 (19990

7.         Wilson E.M., Chinkers M.: Biochemistry 34: 4696-4701 (1995)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2004 – ANNUAL SUBSCRIPTION 2004
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)pharmakonpress[at]pharmakonpress[.]gr
Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)pharmakonpress[at]pharmakonpress[.]gr

 

 

 

Bookmark the permalink.

Comments are closed.